sulfobromophthalein has been researched along with Crush Syndrome in 1 studies
Sulfobromophthalein: A phenolphthalein that is used as a diagnostic aid in hepatic function determination.
Crush Syndrome: Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zarubina, IV | 1 |
| Shabanov, PD | 1 |
1 other study available for sulfobromophthalein and Crush Syndrome
| Article | Year |
|---|---|
[Hepatoprotective properties of cytochrome C in traumatic toxicosis].
Topics: Adenine Nucleotides; Animals; Crush Syndrome; Cytochromes c; Disease Models, Animal; Injections, Int | 2011 |